Activist fans, another lite day. Activist news and stories below. Send tips to @activiststocks, sign up for our daily newsletter, and ICYMI the latest newsletter, it’s here. News: Trian Fund and Nelson Peltz has dumped some of its Legg Mason shares. It lowered its stake by 5% and still owns 10.88% of the company. Kyle Bass is still at it with pharma patent challenges. Today, it’s Jazz Pharmaceuticals and its narcolepsy drug Xyrem. Recall Bass also announced challenges against Shire this week. Elliott Management finally books a win, getting Informatica sold. it’s going private for $48.75 a share. Note that Elliott…
On This Page
This content is exclusively for paying members of Hedge Fund Alpha
Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha
Don’t have an account?
Subscribe now and get 7 days free!
